-
Jiksak Bioengineering Inc. and Teijin Pharma Ltd. signed a joint research agreement to identify novel drug target genes for neurodegenerative diseases.
Sep 2, 2024
News
-
Papers related to our organoid technology have been published.
May 22, 2024
News
-
We have commenced collaborative research and development with Molmir Corporation.
Sep 4, 2023
News
-
Development of Antibodies for Drug Linked Carrier
～Jiksak and MBL announce the jointly developed antibodies for Drug Linked Carrier～
Jul 25, 2023
News
-
Closes 800M JPY Series B funding
Aug 29, 2022
Press Release
-
Mitsui Chemicals, Jiksak Pursue Joint Development in Aim of Commercializing Nerve Tissue Generated From Human iPS Cells
Jul 8, 2022
Press Release
-
Jiksak Gives Webinar with Elixirgen Scientific
Dec 20, 2021
-
Jiksak Selected for Tokyo City’s Advanced Medical Devices Acceleration Program
Oct 28, 2021
News
-
Jiksak and Meiji Enter into a Joint Development Agreement
Aug 17, 2021
News
-
Jiksak’s Nerve Organoids™ Used to Discover New Modulatory Gene for ALS Pathogenesis
Jun 11, 2021
Press Release
-
Jiksak and Sharp Display Technology Announce Jointly Developed Electrode Chip-embedded Nerve Organoid Device
Mar 30, 2021
Press Release
-
Jiksak Partners with Cyberdyne for ALS Drug Discovery and Regenerative Medicine
Mar 23, 2021
Press Release
